Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Assets (2016 - 2025)

CorMedix's Current Assets history spans 13 years, with the latest figure at $367.1 million for Q4 2025.

  • For Q4 2025, Current Assets rose 220.36% year-over-year to $367.1 million; the TTM value through Dec 2025 reached $367.1 million, up 220.36%, while the annual FY2025 figure was $367.1 million, 220.36% up from the prior year.
  • Current Assets for Q4 2025 was $367.1 million at CorMedix, up from $259.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $367.1 million in Q4 2025 and bottomed at $53.2 million in Q2 2024.
  • The 5-year median for Current Assets is $73.0 million (2021), against an average of $109.1 million.
  • The largest annual shift saw Current Assets dropped 24.75% in 2022 before it skyrocketed 366.32% in 2025.
  • A 5-year view of Current Assets shows it stood at $66.5 million in 2021, then dropped by 10.41% to $59.6 million in 2022, then surged by 49.56% to $89.1 million in 2023, then grew by 28.65% to $114.6 million in 2024, then soared by 220.36% to $367.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Current Assets are $367.1 million (Q4 2025), $259.5 million (Q3 2025), and $248.1 million (Q2 2025).